Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus

Biochemistry

Volumn 52, Issue 36, 2013, Pages 6275-6285

  Zhang, Fuming ^a   Aguilera, Javier ^a   Beaudet, Julie M ^a   Xie, Qing ^b   Lerch, Thomas F ^b   Davulcu, Omar ^b   Colón, Wilfredo ^a   Chapman, Michael S ^b   Linhardt, Robert J ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO-ASSOCIATED VIRUS; BINDING AFFINITIES; GLYCOSAMINOGLYCANS; HIGH AFFINITY; SURFACE PLASMON RESONANCE SPECTROSCOPY;

ATOMIC FORCE MICROSCOPY; BINDING ENERGY; PLASMONS; VIRUSES;

POLYSACCHARIDES;

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADENO ASSOCIATED VIRUS; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL ADHESION; CHEMICAL ANALYSIS; CHEMICAL BINDING; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; DENSITY GRADIENT CENTRIFUGATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; TROPISM;

ANIMALS; DEPENDOVIRUS; GLYCOSAMINOGLYCANS; HEPARIN; MICROSCOPY, ATOMIC FORCE; SURFACE PLASMON RESONANCE; SWINE;

EID: 84884249850     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi4008676     Document Type: Article

References (62)

1. Muzyczka, N. and Berns, K. I. (2001) Parvoviridae: The Viruses and Their Replication. In Virology (Fields, B. N., Knipe, D. M., and Howley, P. M., Eds.) 4th ed., pp 2327-2360, Lippincott Williams & Wilkins, Philadelphia.
2. Schambach, A., Maetzig, T., and Baum, C. (2008) Retroviral vectors for Cell and Gene Therapy. In Gene and cell therapy: Therapeutic mechanisms and strategies (Templeton, N. S., Ed.) pp 3-15, CRC Press, Boca Raton, FL.
3. Simonelli, F., Maguire, A. M., Testa, F., Pierce, E. A., Mingozzi, F., Bennicelli, J. L., Rossi, S., Marshall, K., Banfi, S., Surace, E. M., Sun, J., Redmond, T. M., Zhu, X., Shindler, K. S., Ying, G. S., Ziviello, C., Acerra, C., Wright, J. F., McDonnell, J. W., High, K. A., Bennett, J., and Auricchio, A. (2010) Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration Mol. Ther. 18, 643-650
4. Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Roman, A. J., Byrne, B. J., and Jacobson, S. G. (2009) Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis N. Engl. J. Med. 361, 725-727
5. Nathwani, A. C., Tuddenham, E. G., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., O'Beirne, J., Smith, K., Pasi, J., Glader, B., Rustagi, P., Ng, C. Y., Kay, M. A., Zhou, J., Spence, Y., Morton, C. L., Allay, J., Coleman, J., Sleep, S., Cunningham, J. M., Srivastava, D., Basner-Tschakarjan, E., Mingozzi, F., High, K. A., Gray, J. T., Reiss, U. M., Nienhuis, A. W., and Davidoff, A. M. (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B N. Engl. J. Med. 365, 2357-2365
6. Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., and Hunter, L. A. (1991) Targeted Integration of Adenoassociated virus (AAV) into Human Cheomosome-19 EMBO J. 10, 3941-3950
7. Dyall, J., Szabo, P., and Berns, K. I. (1999) Adeno-associated virus (AAV) site-specific integration: Formation of AAV-AAVS1 junctions in an in vitro system Proc. Natl. Acad. Sci. U.S.A. 96, 12849-12854
8. Huttner, N. A., Girod, A., Schnittger, S., Schoch, C., Hallek, M., and Buning, H. (2003) Analysis of site-specific transgene integration following cotransduction with recombinant adeno-associated virus and a rep encodingplasmid J. Gene Med. 5, 120-129
9. Carter, B. J., Burstein, H., and Peluso, R. W. (2008) Adeno-associated Virus and AAV Vectors for Gene delivery. In Gene and cell therapy: Therapeutic mechanisms and strategies (Templeton, N. S., Ed.) pp 115-156, CRC Press, Boca Raton, FL.
10. Gao, G., Lu, Y., Calcedo, R., Grant, R. L., Bell, P., Wang, L., Figueredo, J., Lock, M., and Wilson, J. M. (2006) Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates Mol. Ther. 13, 77-87
11. Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., and Kay, M. A. (2008) In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses J. Virol. 82, 5887-5911
12. Kotchey, N. M., Adachi, K., Zahid, M., Inagaki, K., Charan, R., Parker, R. S., and Nakai, H. (2011) A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction Mol. Ther. 19, 1079-1089
13. Halbert, C. L., Standaert, T. A., Wilson, C. B., and Miller, A. D. (1998) Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure J. Virol. 72, 9795-9805
14. Asokan, A., Hamra, J. B., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R. J. (2006) Adeno-associated virus type 2 contains an integrin α5β1 binding domain essential for viral cell entry J. Virol. 80, 8961-8969
15. Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., and Daida, H. (2005) Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection J. Virol. 79, 609-614
16. Ling, C., Lu, Y., Kalsi, J. K., Jayandharan, G. R., Li, B., Ma, W., Cheng, B., Gee, S. W., McGoogan, K. E., Govindasamy, L., Zhong, L., Agbandje-McKenna, M., and Srivastava, A. (2010) Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3 Hum. Gene Ther. 21, 1741-1747
17. Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., and Chiorini, J. A. (2003) Identification of PDGFR as a receptor for AAV-5 transduction Nat. Med. 9, 1306-1312
18. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Srivastava, A. (1999) Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 Nat. Med. 5, 71-77
19. Akache, B., Grimm, D., Pandey, K., Yant, S. R., Xu, H., and Kay, M. A. (2006) The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 J. Virol. 80, 9831-9836
20. Weller, M. L., Amornphimoltham, P., Schmidt, M., Gutkind, S., and Chiorini, J. A. (2009) Epidermal Growth Factor Receptor is a Receptor for Adeno-Associated Virus Serotype 6. In American Society for Virology, p 80, FASEB, Vancouver, BC.
21. Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E., Eds. (2009) Essentials of glycobiology, 2 nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY.
22. Patel, M., Yanagishita, M., Roderiquez, G., Bou-Habib, D. C., Oravecz, T., Hascall, V. C., and Norcross, M. A. (1993) Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines AIDS Res. Hum. Retroviruses 9, 167-174
23. Saphire, A. C., Bobardt, M. D., and Gallay, P. A. (1999) Host cyclophilin A mediates HIV-1 attachment to target cells via heparans EMBO J. 18, 6771-6785
24. Jackson, T., Ellard, F. M., Ghazaleh, R. A., Brookes, S. M., Blakemore, W. E., Corteyn, A. H., Stuart, D. I., Newman, J. W., and King, A. M. (1996) Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate J. Virol. 70, 5282-5287
25. Zhang, W., Heil, M., Kuhn, R. J., and Baker, T. S. (2005) Heparin binding sites on Ross River virus revealed by electron cryo-microscopy Virology 332, 511-518
26. Gillet, L., Colaco, S., and Stevenson, P. G. (2008) The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH PLoS One 3, e2811
27. Work, L. M., Buning, H., Hunt, E., Nicklin, S. A., Denby, L., Britton, N., Leike, K., Odenthal, M., Drebber, U., Hallek, M., and Baker, A. H. (2006) Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses Mol. Ther. 13, 683-693
28. Perabo, L., Goldnau, D., White, K., Endell, J., Boucas, J., Humme, S., Work, L. M., Janicki, H., Hallek, M., Baker, A. H., and Buning, H. (2006) Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism J. Virol. 80, 7265-7269
29. Wu, Z., Asokan, A., Grieger, J. C., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R. J. (2006) Single Amino Acid Changes Can Influence Titer, Heparin Binding, and Tissue Tropism in Different Adeno-Associated Virus (AAV) Serotypes J. Virol. 80, 11393-11397
30. Asokan, A., Conway, J. C., Phillips, J. L., Li, C., Hegge, J., Sinnott, R., Yadav, S., DiPrimio, N., Nam, H. J., Agbandje-McKenna, M., McPhee, S., Wolff, J., and Samulski, R. J. (2010) Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle Nat. Biotechnol. 28, 79-82
31. Kern, A., Schmidt, K., Leder, C., Muller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., and Kleinschmidt, J. A. (2003) Identification of a heparin-binding motif on adeno-associated virus type 2 capsids J. Virol. 77, 11072-11081
32. Muller, O. J., Leuchs, B., Pleger, S. T., Grimm, D., Franz, W. M., Katus, H. A., and Kleinschmidt, J. A. (2006) Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors Cardiovasc. Res. 70, 70-78
33. Handa, A., Muramatsu, S., Qiu, J., Mizukami, H., and Brown, K. E. (2000) Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors J. Gen. Virol. 81, 2077-2084
34. Summerford, C. and Samulski, R. J. (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J. Virol. 72, 1438-1445
35. Lerch, T. F. and Chapman, M. S. (2012) Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B) Virology 423, 6-13
36. Xie, Q., Lerch, T. F., Meyer, N. L., and Chapman, M. S. (2011) Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6) Virology 420, 10-19
37. Wu, Z., Miller, E., Agbandje-McKenna, M., and Samulski, R. J. (2006) α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6 J. Virol. 80, 9093-9103
38. Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., and Chiorini, J. A. (2001) Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity J. Virol. 75, 6884-6893
39. Shen, S., Bryant, K. D., Sun, J., Brown, S. M., Troupes, A., Pulicherla, N., and Asokan, A. (2012) Glycan binding avidity determines the systemic fate of adeno-associated virus type 9 J. Virol. 86, 10408-10417
40. Bell, C. L., Gurda, B. L., Van Vliet, K., Agbandje-McKenna, M., and Wilson, J. M. (2012) Identification of the galactose binding domain of the AAV9 capsid J. Virol. 86, 7326-7333
41. Capila, I. and Linhardt, R. J. (2002) Heparin-protein interactions Angew. Chem., Int. Ed. 41, 391-412
42. Hacker, U., Nybakken, K., and Perrimon, N. (2005) Heparan sulphate proteoglycans: The sweet side of development Nat. Rev. Mol. Cell Biol. 6, 530-541
43. Parish, C. R. (2006) The role of heparan sulphate in inflammation Nat. Rev. Immunol. 6, 633-643
44. Powell, A. K., Yates, E. A., Fernig, D. G., and Turnbull, J. E. (2004) Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and experimental approaches Glycobiology 14, 17R-30R
45. Sasisekharan, R., Raman, R., and Prabhakar, V. (2006) Glycomics approach to structure-function relationships of glycosaminoglycans Annu. Rev. Biomed. Eng. 8, 181-231
46. Brister, S. J., Buchanan, M. R., Griffin, C. C., Van Gorp, C. L., and Linhardt, R. J. (1999) Dermatan disulfate, an inhibitor of thrombin and complement activation. U.S. Patent 5,922,690.
47. 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives Carbohydr. Res. 294, 15-27
48. Urabe, M., Ding, C., and Kotin, R. M. (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors Hum. Gene Ther. 13, 1935-1943
49. Lerch, T. F., O'Donnell, J. K., Meyer, N. L., Xie, Q., Taylor, K. A., Stagg, S. M., and Chapman, M. S. (2012) Structure of AAV-DJ, a Retargeted Gene Therapy Vector: Cryo-Electron Microscopy at 4.5 Å Resolution Structure 20, 1310-1320
50. Xie, Q., Ongley, H. M., Hare, J., and Chapman, M. S. (2008) Crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 6 Acta Crystallogr. F64, 1074-1078
51. Hernaiz, M., Liu, J., Rosenberg, R. D., and Linhardt, R. J. (2000) Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III Biochem. Biophys. Res. Commun. 276, 292-297
52. O'Donnell, J., Taylor, K. A., and Chapman, M. S. (2009) Adeno-associated virus-2 and its primary cellular receptor: Cryo-EM structure of a heparin complex Virology 385, 434-443
53. Kirschner, K. N., Yongye, A. B., Tschampel, S. M., Gonzalez-Outeirino, J., Daniels, C. R., Foley, B. L., and Woods, R. J. (2008) GLYCAM06: A generalizable biomolecular force field. Carbohydrates J. Comput. Chem. 29, 622-655
54. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot Acta Crystallogr. D66, 486-501
55. Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L., and Schulten, K. (2005) Scalable molecular dynamics with NAMD J. Comput. Chem. 26, 1781-1802
56. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific, San Carlos, CA.
57. Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., and Chapman, M. S. (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy Proc. Natl. Acad. Sci. U.S.A. 99, 10405-10410
58. McCraw, D. M., O'Donnell, J. K., Taylor, K. A., Stagg, S. M., and Chapman, M. S. (2012) Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20 Virology 431, 40-49
59. Opie, S. R., Warrington, K. H., Jr., Agbandje-McKenna, M., Jr., Zolotukhin, S., and Muzyczka, N. (2003) Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding J. Virol. 77, 6995-7006
60. Zhang, F., McLellan, J. S., Ayala, A. M., Leahy, D. J., and Linhardt, R. J. (2007) Kinetic and structural studies on interactions between heparin or heparan sulfate and proteins of the hedgehog signaling pathway Biochemistry 46, 3933-3941
61. Zhang, F., Zhang, Z., Lin, X., Beenken, A., Eliseenkova, A. V., Mohammadi, M., and Linhardt, R. J. (2009) Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor· fibroblast growth factor receptor complexes Biochemistry 48, 8379-8386
62. Zhang, F., Walcott, B., Zhou, D., Gustchina, A., Lasanajak, Y., Smith, D. F., Ferreira, R. S., Correia, M. T., Paiva, P. M., Bovin, N. V., Wlodawer, A., Oliva, M. L., and Linhardt, R. J. (2013) Structural Studies of the Interaction of Crataeva tapia Bark Protein with Heparin and Other Glycosaminoglycans Biochemistry 52, 2148-2156